CTTI maps novel endpoints to accelerate mobile tech use in clinical trials
The Clinical Trials Transformation Initiative (CTTI) has released novel endpoint recommendations to catalyze mobile technology use in clinical trials.
Archives for July 5, 2017
PRA to conduct Ph Ib/II clinical trial of PLK1 inhibitor
Trovagene, Inc. has contracted PRA Health Sciences to conduct its Phase Ib/II clinical trial of PCM-075 in patients with acute myeloid leukemia (AML).
Bayer ends methamphetamine abuse deterrent partnership with Acura
Bayer has pulled-out of a development and licensing deal for a pseudoephedrine containing product based on Acura Pharmaceuticals’ methamphetamine resistant technology, Impede.
EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine
German Merck and Sigma-Aldrich broke EU merger procedures and could face a fine equivalent to 1% of the combined firm's annual revenue according to the European Commission
update
Pacira to stop making DepoCyt due to long-term production problems
Pacira Pharmaceuticals Inc. has said it will stop making the cancer DepoCyt (cytarabine), citing persistent manufacturing problems.
PMDA confirms investigation of Osaka API firm Yamamoto Chemical
Japanese regulators are investigating allegations API firm Yamamoto Chemical Industry gave inspectors false information and improperly bulked-up batches of acetaminophen and zonisamide.
DIA 2017
Greenphire launches payments advisory group for CROs
The goal of the group is to provide a platform for contract research organizations (CROs) to help shape the payment automation market.